Bittium Corporations subsidiary Bittium Biosignals Ltd and Preventice Solutions have signed an extension agreement for the supply of ECG monitoring devicesBittium Biosignals Ltd a subsidiary of Bittium Corporation and Preventice Solutions a wholly owned subsidiary of Boston Scientific have today signed an agreement by which Bittium will extend its supply of BodyGuardian MINI devices for monitoring cardiac arrhythmias to Preventice Solutions. In addition according to the agreement the parties will continue to cooperate in the development of new tailored ECG technology for Preventice Solutions.When the minimum volumes required for the exclusive rights under the agreement are met the total value of the agreement signed today is approximately USD 40-45 million approximately EUR 35-40 million based on an exchange rate of February 1 2022 with revenues accruing during 2022 2023 2024 and 2025. The final total value is mainly affected by the purchase volumes of different product models.The cooperation between Bittium and Preventice Solutions began in February 2018 regarding the development and delivery of wireless ECG measurement devices. The cooperation resulted in the development of the worlds first IP67-classified BodyGuardian MINI EL Holter monitor capable of 16-day recording with excellent wearability for ease of use and convenience. The cooperation was announced on February 13 2018 and the continuation of the cooperation was announced on September 10 2020. The agreement signed today replaces the extension agreement signed in September 2020 for the supply of ECG measuring devices for the years 2021-2024.We are happy to strengthen this strategic relationship with this agreement. Preventice is a market leader specializing in remote cardiac monitoring services and together with Bittiums nearly 40 years of experience in biosignal processing and wireless technologies we can offer leading electronic cardiac monitoring solutions to the markets said Hannu Huttunen president and CEO of Bittium.Under these agreements Bittium has provided Preventice Solutions with customized wireless ECG measurement and monitoring equipment for the last four years. Bittium offers state-of-the-art ECG technology which together with Preventice Solutions has been customized and further developed to improve the physician and patient experience in remote cardiac monitoring. Preventice Solutions has the exclusive right to use resell and market tailored BodyGuardian MINI EL ECG devices as part of its own remote diagnostic services offering globally and the exclusive right to use resell and market the BodyGuardian MINI SL ECG devices in the United States. The BodyGuardian MINI product family of ECG sensors continuously records electrocardiographic waveforms and provides multiple uses on the same device including short- and long-term Holter measurements Cardiac Event Monitoring CEM and Mobile Cardiac Telemetry MCT.We are pleased to extend the agreement with Bittium to ensure healthcare professionals and their patients continue to have access to the BodyGuardian MINI devices which enable clinicians to make timely data-driven decisions said Scott Olson senior vice president and president Cardiac Rhythm Management and Diagnostics Boston Scientific.
🔍 Key Information
📄
Tender Reference No.
469927634
📅
Publication Date
04 Feb 2022
🌐
Sector
Information Technology (IT)
📝
Notice Type
News
📍
Location
Finland
📁
Documents & Downloads
No documents found
🏷️ CPV
No CPV found
Need help with this bid?
Our bid experts can help you find, evaluate & win more tenders.